Top Markets
#1 TENDIES TENDIES +31.34%
#2 ICON ICON +26.61%
#3 Cash Cat Cash Cat +22.92%
#4 Threshold Network Threshold Network +20.14%
#5 OSK OSK +15.74%
#6 Magma Finance Magma Finance +12.58%
#7 Asteroid Shiba Asteroid Shiba +12.44%
#8 Ape and Pepe Ape and Pepe +11.65%
#9 Kite Kite +11.54%
#10 龙虾 (Lobster) 龙虾 (Lobster) +10.56%
Coin of the day
TENDIES TENDIES
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
Clasificación en acciones #16900
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
Precio por acción
$2.46
Capitalización bursátil
$268.65M
Cambio (1 día)
-1.73%
Cambio (1 año)
-57.06%
País
CN
Comercio VISEN Pharmaceuticals (2561)

Categoría

Healthcare
Ingresos de VISEN Pharmaceuticals (2561)
Ingresos en Sep 2026 TTM: 0
Según los últimos informes financieros de VISEN Pharmaceuticals, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de VISEN Pharmaceuticals desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH